![Heart podcast show](https://d3dthqtvwic6y7.cloudfront.net/podcast-covers/000/043/727/small/heart-podcasts.jpg)
Summary: Alistair Lindsey talks to Christopher Cannon, Havard Clinical Research Institute, about the results of his IMPROVE-IT trial, which examined clinical outcomes of adding ezetimibe to simvastatin. <p>This podcast was recorded at the American Heart Association scientific sessions in Chicago.</p>